{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:58:15Z","timestamp":1791197895419,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H160006"],"award-info":[{"award-number":["LQ22H160006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ19H030010"],"award-info":[{"award-number":["LQ19H030010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05497-9","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:27:45Z","timestamp":1742174865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early predictors of induction of remission with exclusive enteral nutrition in children with Crohn\u2019s disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Yudie","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"5497_CR1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/s0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s disease. Lancet. 2017;389:1741\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(16)31711-1","journal-title":"Lancet"},{"key":"5497_CR2","doi-asserted-by":"publisher","unstructured":"Roda G, Ng SC, Kotze PG, et al. Crohn\u2019s disease. Nat Reviews Disease Primers. 2020;6. https:\/\/doi.org\/10.1038\/s41572-020-0156-2","DOI":"10.1038\/s41572-020-0156-2"},{"key":"5497_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","volume":"26","author":"YR Yu","year":"2017","unstructured":"Yu YR, Rodriguez JR. Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26:349\u201355. https:\/\/doi.org\/10.1053\/j.sempedsurg.2017.10.003","journal-title":"Semin Pediatr Surg"},{"key":"5497_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa161","author":"PF van Rheenen","year":"2020","unstructured":"van Rheenen PF, Aloi M, Assa A, et al. The Medical Management of Paediatric Crohn\u2019s Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa161","journal-title":"J Crohns Colitis"},{"key":"5497_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clnu.2018.01.020","volume":"38","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn\u2019s disease: evidence and practicalities. Clin Nutr. 2019;38:80\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2018.01.020","journal-title":"Clin Nutr"},{"key":"5497_CR6","doi-asserted-by":"publisher","unstructured":"Hansen T, Duerksen DR. Enteral Nutrition in the Management of Pediatric and Adult Crohn\u2019s Disease. Nutrients. 2018;10. https:\/\/doi.org\/10.3390\/nu10050537","DOI":"10.3390\/nu10050537"},{"key":"5497_CR7","doi-asserted-by":"publisher","first-page":"3813915","DOI":"10.1155\/2022\/3813915","volume":"2022","author":"Y Lv","year":"2022","unstructured":"Lv Y, Lou Y, Yang G, et al. Outcomes of Pediatric patients with Crohn\u2019s Disease received Infliximab or Exclusive Enteral Nutrition during induction remission. Gastroenterol Res Pract. 2022;2022:3813915. https:\/\/doi.org\/10.1155\/2022\/3813915","journal-title":"Gastroenterol Res Pract"},{"key":"5497_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3748\/wjg.v22.i3.1045","volume":"22","author":"A Wedrychowicz","year":"2016","unstructured":"Wedrychowicz A, Zajac A, Tomasik P. Advances in nutritional therapy in inflammatory bowel diseases: review. World J Gastroenterol. 2016;22:1045\u201366. https:\/\/doi.org\/10.3748\/wjg.v22.i3.1045","journal-title":"World J Gastroenterol"},{"key":"5497_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/mpg.0000000000000239","volume":"58","author":"A Levine","year":"2014","unstructured":"Levine A, Koletzko S, Turner D, et al. ESPGHAN revised Porto Criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795\u2013806. https:\/\/doi.org\/10.1097\/mpg.0000000000000239","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5497_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ibd.21649","volume":"18","author":"D Turner","year":"2012","unstructured":"Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn\u2019s disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55\u201362. https:\/\/doi.org\/10.1002\/ibd.21649","journal-title":"Inflamm Bowel Dis"},{"key":"5497_CR11","doi-asserted-by":"publisher","first-page":"913720","DOI":"10.3389\/fphar.2022.913720","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Lu Z, Kang D, et al. Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn\u2019s disease. Front Pharmacol. 2022;13:913720. https:\/\/doi.org\/10.3389\/fphar.2022.913720","journal-title":"Front Pharmacol"},{"key":"5497_CR12","doi-asserted-by":"publisher","first-page":"6595048","DOI":"10.1155\/2017\/6595048","volume":"2017","author":"Y Luo","year":"2017","unstructured":"Luo Y, Yu J, Lou J, et al. Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn\u2019s Disease. Gastroenterol Res Pract. 2017;2017:6595048. https:\/\/doi.org\/10.1155\/2017\/6595048","journal-title":"Gastroenterol Res Pract"},{"key":"5497_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/gastro\/goy050","volume":"7","author":"JM Chen","year":"2019","unstructured":"Chen JM, He LW, Yan T, et al. Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn\u2019s disease. Gastroenterol Rep (Oxf). 2019;7:176\u201384. https:\/\/doi.org\/10.1093\/gastro\/goy050","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"5497_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","volume":"169","author":"MJ Rosen","year":"2015","unstructured":"Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. Jama Pediatr. 2015;169:1053\u201360. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.1982","journal-title":"Jama Pediatr"},{"key":"5497_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.Mib.0000440817.84251.98","volume":"20","author":"M Lenicek","year":"2014","unstructured":"Lenicek M, Duricova D, Hradsky O, et al. The relationship between serum bilirubin and Crohn\u2019s Disease. Inflamm Bowel Dis. 2014;20:481\u20137. https:\/\/doi.org\/10.1097\/01.Mib.0000440817.84251.98","journal-title":"Inflamm Bowel Dis"},{"key":"5497_CR16","doi-asserted-by":"publisher","unstructured":"Zhao X, Li L, Li X, et al. The relationship between serum bilirubin and inflammatory bowel disease. Mediat Inflamm. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/5256460","DOI":"10.1155\/2019\/5256460"},{"key":"5497_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.crohns.2011.11.010","volume":"6","author":"HS de Vries","year":"2012","unstructured":"de Vries HS, te Morsche RHM, Jenniskens K, et al. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn\u2019s disease. J Crohns Colitis. 2012;6:597\u2013602. https:\/\/doi.org\/10.1016\/j.crohns.2011.11.010","journal-title":"J Crohns Colitis"},{"key":"5497_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.gastro.2014.03.049","volume":"147","author":"A Vossenkaemper","year":"2014","unstructured":"Vossenkaemper A, Hundsrucker C, Page K, et al. A CD3-Specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease. Gastroenterology. 2014;147:172\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2014.03.049","journal-title":"Gastroenterology"},{"key":"5497_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/MCO.0b013e328349eb4d","volume":"14","author":"MP Tighe","year":"2011","unstructured":"Tighe MP, Cummings JR, Afzal NA. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr Opin Clin Nutr Metab Care. 2011;14:491\u20136. https:\/\/doi.org\/10.1097\/MCO.0b013e328349eb4d","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"5497_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gut.2010.216929","volume":"60","author":"T Werner","year":"2011","unstructured":"Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn\u2019s disease-like ileitis. Gut. 2011;60:325\u201333. https:\/\/doi.org\/10.1136\/gut.2010.216929","journal-title":"Gut"},{"key":"5497_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","volume":"371","author":"G D\u2019Haens","year":"2008","unstructured":"D\u2019Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: an open randomised trial. Lancet. 2008;371:660\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(08)60304-9","journal-title":"Lancet"},{"key":"5497_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/ecco-jcc\/jjw075","volume":"10","author":"Z Grover","year":"2016","unstructured":"Grover Z, Burgess C, Muir R, et al. Early Mucosal Healing with Exclusive Enteral Nutrition Is Associated with Improved outcomes in newly diagnosed children with Luminal Crohn\u2019s disease. J Crohns Colitis. 2016;10:1159\u201364. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw075","journal-title":"J Crohns Colitis"},{"key":"5497_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","volume":"138","author":"F Baert","year":"2010","unstructured":"Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease. Gastroenterology. 2010;138:463\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2009.09.056. quiz e410-461.","journal-title":"Gastroenterology"},{"key":"5497_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gut.49.1.42","volume":"49","author":"JF Colombel","year":"2001","unstructured":"Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn\u2019s disease. Gut. 2001;49:42\u20136. https:\/\/doi.org\/10.1136\/gut.49.1.42","journal-title":"Gut"},{"key":"5497_CR25","doi-asserted-by":"publisher","unstructured":"Lai W, Xian C, Chen M, et al. Single-cell and bulk transcriptomics reveals M2d macrophages as a potential therapeutic strategy for mucosal healing in ulcerative colitis. Int Immunopharmacol. 2023;121. https:\/\/doi.org\/10.1016\/j.intimp.2023.110509","DOI":"10.1016\/j.intimp.2023.110509"},{"key":"5497_CR26","doi-asserted-by":"publisher","unstructured":"Wilke CM, Wang L, Wei S, et al. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. J Translational Med. 2011;9. https:\/\/doi.org\/10.1186\/1479-5876-9-217","DOI":"10.1186\/1479-5876-9-217"},{"key":"5497_CR27","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1172\/JCI90229","volume":"127","author":"M Quiros","year":"2017","unstructured":"Quiros M, Nishio H, Neumann PA, et al. Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling. J Clin Invest. 2017;127:3510\u201320. https:\/\/doi.org\/10.1172\/JCI90229","journal-title":"J Clin Invest"},{"key":"5497_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00054725-200309000-00005","volume":"9","author":"AD de Silva","year":"2003","unstructured":"de Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis. 2003;9:316\u201320. https:\/\/doi.org\/10.1097\/00054725-200309000-00005","journal-title":"Inflamm Bowel Dis"},{"key":"5497_CR29","first-page":"A68","volume":"126","author":"G Semrin","year":"2004","unstructured":"Semrin G, Andrews NC, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn\u2019s disease correlates with disease activity and inflammatory cytokines. Gastroenterology. 2004;126:A68\u201368.","journal-title":"Gastroenterology"},{"key":"5497_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5009\/gnl.2011.5.4.460","volume":"5","author":"A Yesil","year":"2011","unstructured":"Yesil A, Senates E, Bayoglu IV, et al. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver. 2011;5:460\u20137. https:\/\/doi.org\/10.5009\/gnl.2011.5.4.460","journal-title":"Gut Liver"},{"key":"5497_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41430-018-0198-7","volume":"72","author":"M Xue","year":"2018","unstructured":"Xue M, Zhang H, Wang X, et al. Efficacy predictors of a 2-month exclusive enteral nutrition for inducing remission of active Crohn\u2019s disease. Eur J Clin Nutr. 2018;72:1183\u20136. https:\/\/doi.org\/10.1038\/s41430-018-0198-7","journal-title":"Eur J Clin Nutr"},{"key":"5497_CR32","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1097\/mib.0000000000000956","volume":"22","author":"KA Dunn","year":"2016","unstructured":"Dunn KA, Moore-Connors J, MacIntyre B, et al. Early changes in Microbial Community structure are Associated with Sustained Remission after Nutritional Treatment of Pediatric Crohn\u2019s Disease. Inflamm Bowel Dis. 2016;22:2853\u201362. https:\/\/doi.org\/10.1097\/mib.0000000000000956","journal-title":"Inflamm Bowel Dis"},{"key":"5497_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ecco-jcc\/jjab157","volume":"16","author":"AR Bourgonje","year":"2022","unstructured":"Bourgonje AR, Hu S, Spekhorst LM, et al. The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease. J Crohns Colitis. 2022;16:414\u201329. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab157","journal-title":"J Crohns Colitis"},{"key":"5497_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae107","author":"B White","year":"2024","unstructured":"White B, Svolos V, Gervais L, et al. Inflammation-related proteins support diagnosis of inflammatory bowel disease and are modified by Exclusive Enteral Nutrition in Children with Crohn\u2019s Disease, especially of Ileal phenotype. Inflamm Bowel Dis. 2024. https:\/\/doi.org\/10.1093\/ibd\/izae107","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05497-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05497-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05497-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:27:47Z","timestamp":1742174867000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05497-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5497"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05497-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4592049\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethical Committee of Children\u2019s Hospital, Zhejiang University School of Medicine, under 2019-IRB-109. Written consent was obtained from the children and their legal guardians before the samples were collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}